The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility
Open accessThe DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index; none of the 56 sources its claims cite is checked for support yet.
Abstract
Background: Many benefits and some harms associated with psychedelic use could be attributable to these drugs’ acceptance/avoidance-promoting effects and corresponding changes in psychological flexibility. Underlying psychological mechanisms are insufficiently understood. Aim: The purpose of this study was the validation of a psychological model of acceptance/avoidance-promoting psychedelic experiences, which included the development of a theory-based self-report instrument: the Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ). Its two main scales, acceptance-related experience (ACE) and avoidance-related experience (AVE), represent the theorized model’s core constructs. We aimed to test the model’s central assumptions of complementarity (ACE and AVE may occur alternatingly but not simultaneously, and are therefore empirically independent), intertwinedness (subaspects within ACE and AVE are mutually contingent and therefore highly inter-correlated), context-dependence (ACE and AVE depend on context factors) and interaction (longer-term outcomes depend on the interplay between ACE and AVE). Method: A bilingual retrospective online survey including 997 English- and 836 German-speaking participants. Each participant reported on one psychedelic experience occasioned by lysergic acid diethylamide (LSD), psilocybin, mescaline, or ayahuasca. Results: Whereas ACE and AVE were found to be relatively independent aspects of participants’ reported psychedelic experiences (complementarity), their subaspects were mostly distinguishable but strongly correlated among each other (intertwinedness). Therapeutic, escapist, and hedonic use motives were differentially associated with ACE and AVE (context-dependence), which were in turn associated with retrospective changes in psychological flexibility following participants’ reported experiences. The positive association between ACE and increased psychological flexibility was significantly moderated by AVE (interaction). Conclusion: These results provide an initial validation of the APEQ and its underlying theoretical model, suggesting the two can help clarify the psychological mechanisms of psychedelic-induced benefits and harms. Both should be further investigated in prospective-longitudinal and clinical studies.
Overview
CoChat Summary
## TL;DR
The paper develops and initially validates the bilingual Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ) to measure acceptance- and avoidance-promoting psychedelic experiences and test a model linking them to psychological flexibility. In a retrospective online survey of 1,829 participants, the core model was largely supported: ACE and AVE were relatively independent, their subaspects were strongly correlated, and both predicted retrospective changes in psychological flexibility.
## Key findings
- The final sample was 1,829 participants: 997 English-speaking and 832 German-speaking; 45 volunteers were excluded after initial completion for speeding, multiple psychedelic use, invalid feedback, or poor memory.
- PCA of 22 use motives yielded a 3-component solution explaining 44.2% of the variance, labeled therapeutic intention, escapist intention, and hedonic intention.
- The final measurement model fit was acceptable in both replication strata: English RMSEA = 0.047, CFI = 0.923, SRMR = 0.066; German RMSEA = 0.056, CFI = 0.911, SRMR = 0.076. The ACE–AVE correlation was non-significant in English (r = −0.06) and weakly negative in German (r = −0.18).
- In the SEM, ACE was positively associated with retrospective increases in psychological flexibility (β = 0.500; p < 0.001), while AVE was negatively associated (β = −0.077; p = 0.013). The ACE × AVE interaction was significant (β = 0.090; p = 0.005).
- External validity was supported by strong correlations: ACE with EBI (r = 0.81, p < 0.001) and AVE with CEQ (r = 0.75, p < 0.001). The short form APEQ-S correlated very strongly with the long form (ACE r = 0.97; AVE r = 0.96–0.97).
## Methods
- Design/sample: Bilingual retrospective anonymous online survey conducted October 2020–March 2021 with English- and German-speaking volunteers; participants reported on one memorable psychedelic experience from at least 1 month earlier occasioned by LSD, psilocybin, mescaline, or ayahuasca.
- Instrument development: The authors created the theory-based APEQ in parallel English and German development, using 57 candidate items, later reduced to a 32-item long form and a 12-item short form (APEQ-S).
- Analysis: Data cleaning removed invalid responses; PCA was used for use motives; CFAs were used for item selection/model testing and replication across matched English/German selection and replication strata; SEM tested context-dependence and interaction with retrospective psychological-flexibility change; correlations examined construct validity with EBI and CEQ.
## Limitations
- The paper states that the anonymous online survey means responses cannot be verified, and duplicate participants cannot be ruled out.
- The authors note self-selection/participation bias and that people with negative attitudes toward psychedelics and highly avoidance-promoting experiences may be under-represented; this may partly explain the relatively low AVE scores.
- The paper states that the cross-sectional retrospective design is susceptible to recall bias and does not allow causal inferences; it calls for prospective studies.
- Evident from the text: the psychological-flexibility outcome and all experience ratings are retrospective, so the direction of effects is inferential rather than observed prospectively.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
0 Valid · 0 Not valid · 38 Not checked · 104 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therapeutic, escapist, and hedonic use motives were differentially associated with ACE and AVE (context-dependence),”
- Also stated in: § Results: · plain
“Therapeutic, escapist, and hedonic use motives were differentially associated with ACE and AVE (context-dependence)”
§ The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility > Abstract > Results:
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results: · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Whereas ACE and AVE were found to be relatively independent aspects of participants’ reported psychedelic experiences (complementarity)”
§ The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility > Abstract > Results:
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“which were in turn associated with retrospective changes in psychological flexibility following participants’ reported experiences.”
§ The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility > Abstract > Results:
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The positive association between ACE and increased psychological flexibility was significantly moderated by AVE (interaction).”
§ The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility > Abstract > Results:
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Levels of distress were strongly associated with avoidant responding and pro-avoidance insights.”
§ The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility > Discussion > Evidence of complementarity and intertwinedness Development of the APEQ was based on the central premises of complementarity (the assumption that contrasting acceptance- and avoidance-related experiential aspects cannot occur simultaneously but may alternate over the course of a psychedelic experience) and intertwinedness (the assumption that distinguishable subaspects within the acceptance- and avoidance-related domain typically co-occur and correspond to one another in magnitude). In accordance with the assumption of complementarity, we found that ACE and AVE were indeed not only distinguishable but also largely independent factors. In contrast, and in line with the assumption of intertwinedness, subaspects within ACE and AVE were found to be highly positively correlated: Levels of distress were strongly associated with avoidant responding and pro-avoidance insights. Likewise, experiences of relief were strongly associated with accepting responses and pro-acceptance insights. Associations between the latter two were in fact so strong that the baseline model and a model where both were collapsed into one factor fit the data comparably well in both selection strata. Note, however, that the non-significance of χ2 difference tests for model comparisons was indeed marginal in both samples. Therefore, and based on the theoretical consideration that accepting responses to aversive private events must not always inevitably lead to insights that promote acceptance (e.g. when acceptance-promoting beliefs with respect to the same private events have already been held previously), we propose to maintain both subscales and further investigate their dissociability in future prospective studies.
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
71 more claims
Create a free account to see all 142 claims and to verify the 56 references still open.
- It may state two separate claims as one. 46
- Probably not a substantial claim. 28
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Psychedelics, on the other hand, can lead to profound insights into personal values, and in this way enhance psychological flexibility [92].”
From Mindfulness meditation and psychedelics: potential synergies and commonalities (2023) · cites this paper as [92]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Current research points toward specific traits of the psychedelic experience as relevant mediators of the therapeutic outcomes of PAP, such as acceptance-related experiences, the presence of mystical experiences, or the reappraisal of negative emotion (52–55).”
From Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol (2025) · cites this paper as [52]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The Acceptance/Avoidance-Promoting Experiences Questionnaire quantifies experiential acceptance (the ability to tolerate, allow, and engage with aversive feelings, emotions, or memories) and avoidance (the tendency to avoid said feelings and thoughts despite negative consequences) in the context of psychedelic use (Wolff et al., 2022).”
From Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics (2024) · cites this paper as Wolff et al., 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility > Results > Participants
“Characteristics of the final sample of 1829 participants (997 in the English sample and 832 in the German sample) are presented in Table 1.”
§ The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility > Abstract > Method:
“A bilingual retrospective online survey including 997 English- and 836 German-speaking participants.”
Citations
Cites
Confirmatory factor analysis for applied research
(2007) · Choice Reviews Online · doi:10.5860/choice.44-2769 · Cited by 15,614 · cited 1×
“Following recommendations by Brown (2015), the Root-Mean Square Error of Approximation (RMSEA), the Confirmatory Fit Index (CFI), and the standardized root mean square residual (SRMR) were calculated as fit indices.”
MethodA scaled difference chi-square test statistic for moment structure analysis
Satorra, A., & Bentler, P. M. (2001) · Psychometrika · doi:10.1007/bf02296192 · Cited by 5,282
Symonds, P. M. (1954) · Journal of Educational Psychology · doi:10.1037/h0051901 · Cited by 4,875
Equivalence of the Mediation, Confounding and Suppression Effect
MacKinnon, D. P., Krull, J. L., & Lockwood, C. M. (2000) · Prevention Science · doi:10.1023/a:1026595011371 · Cited by 4,188 · cited 1×
“The sum of both indirect effects was similar in size to the antagonistic direct effect, indicating the presence of a suppression effect (MacKinnon et al., 2000).”
BackgroundBond, F. W., Hayes, S. C., Baer, R. A., Carpenter, K. M., Guenole, N., Orcutt, H. K., Waltz, T., & Zettle, R. D. (2011) · Behavior Therapy · doi:10.1016/j.beth.2011.03.007 · Cited by 3,950 · cited 2×
“The Acceptance and Action Questionnaire II (AAQ-II; Bond et al., 2011; German version by Hoyer and Gloster, 2013), measures psychological (in-)flexibility using seven items (e.”
MethodPsychological flexibility as a fundamental aspect of health
Kashdan, T. B., & Rottenberg, J. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.03.001 · Cited by 3,054 · cited 2×
“Email: max.wolff@mind-foundation.org Acceptance is fundamental to psychological flexibility, a crucial aspect of emotional well-being and a central target of psychotherapy (most notably the “third wave” cognitive-behavioral therapies; Kashdan and Rottenberg, 2010).”
BackgroundEnsuring Positiveness of the Scaled Difference Chi-square Test Statistic
Satorra, A., & Bentler, P. M. (2010) · Psychometrika · doi:10.1007/s11336-009-9135-y · Cited by 2,695
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 2×
“Converging evidence from psychometric tests (Carhart-Harris et al., 2021; Griffiths et al., 2016), neuroimaging studies (Mertens et al., 2020; Roseman et al., 2018), and qualitative interviews with patients (Belser et al., 2017; Gasser et al., 2015; Watts et al., 2017) suggests that these drugs’…”
BackgroundJournal of Transpersonal Psychology
(1977) · Journal of Humanistic Psychology · doi:10.1177/002216787701700308 · Cited by 1,732
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698 · cited 2×
“…with chronic or terminal illness (Agin-Liebes et al., 2020; Anderson et al., 2020; Gasser et al., 2014; Griffiths et al., 2016; Grob et al., 2011; Ross et al., 2016), obsessive-compulsive disorder (Moreno et al., 2006), and substance use disorders (Bogenschutz et al., 2015; Johnson et al., 2014,…”
BackgroundDrug harms in the UK: a multicriteria decision analysis
Nutt, D. J., King, L. A., & Phillips, L. D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61462-6 · Cited by 1,681 · cited 2×
“Much less discussed in the literature, presumably because severe psychedelic-induced harm is relatively rare (Nutt et al., 2010; Van Amsterdam et al., 2015), is the possibility that experiential avoidance is not reduced but rather enduringly increased following a psychedelic experience, leading to psychological inflex…”
BackgroundAdapting Educational and Psychological Tests for Cross-Cultural Assessment
(2004) · Psychology Press eBooks · doi:10.4324/9781410611758 · Cited by 1,627
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
Trial of Psilocybin versus Escitalopram for Depression
Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., Martell, J., Blemings, A., Erritzoe, D., & Nutt, D. J. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032994 · Cited by 1,391 · cited 2×
“Converging evidence from psychometric tests (Carhart-Harris et al., 2021; Griffiths et al., 2016), neuroimaging studies (Mertens et al.”
BackgroundEffects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial
Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3285 · Cited by 1,301 · cited 4×
“Further evidence that longer-term impacts of challenging psychedelic experiences depend on additional factors was recently presented by Davis et al. (2021).”
BackgroundMethodInfluentialPilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206 · cited 2×
“, 2019), psychological distress associated with chronic or terminal illness (Agin-Liebes et al., 2020; Anderson et al., 2020; Gasser et al., 2014; Griffiths et al., 2016; Grob et al., 2011; Ross et al., 2016), obsessive-compulsive disorder (Moreno et al.”
BackgroundHuman hallucinogen research: guidelines for safety
Johnson, M., Richards, W., & Griffiths, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108093587 · Cited by 1,203 · cited 2×
“At a closer look, most recommendations according to current standard protocols for psychedelic therapy (Garcia-Romeu and Richards, 2018), guidelines for human research with psychedelics (Johnson et al., 2008), and psychedelic harm reduction practices (Gorman et al.”
BackgroundREBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics
Carhart-Harris, R. L., & Friston, K. J. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017160 · Cited by 1,180 · cited 5×
“…are not well understood and remain to be studied experimentally, we have proposed that the effect emerges when psychedelic-induced belief relaxation (Carhart-Harris and Friston, 2019) allows avoidance-related motivational processes (e.g. implicit representations of avoidance goals) to infiltrate…”
BackgroundInfluentialPsilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151 · cited 1×
“…chronic or terminal illness (Agin-Liebes et al., 2020; Anderson et al., 2020; Gasser et al., 2014; Griffiths et al., 2016; Grob et al., 2011; Ross et al., 2016), obsessive-compulsive disorder (Moreno et al., 2006), and substance use disorders (Bogenschutz et al., 2015; Johnson et al., 2014, 2017).”
BackgroundFrank, J. (1993) · doi:10.56021/9780801840678 · Cited by 1,094
Seligman, M. E. P. (1972) · Annual Review of Medicine · doi:10.1146/annurev.me.23.020172.002203 · Cited by 1,071 · cited 1×
“Parallels between this condition and “learned helplessness” (Seligman, 1972), that is, perceived lack of control over reinforcement, may suggest that depressed or demoralized individuals will remain in this state for longer periods of time (and point toward another potential therapeutic mechanism).”
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4771-x · Cited by 970
Handbook of Psychotherapy and Behavior Change
Kepecs, J. G. (1980) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1980.34.1.131 · Cited by 962
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114548296 · Cited by 914 · cited 1×
“…chronic or terminal illness (Agin-Liebes et al., 2020; Anderson et al., 2020; Gasser et al., 2014; Griffiths et al., 2016; Grob et al., 2011; Ross et al., 2016), obsessive-compulsive disorder (Moreno et al., 2006), and substance use disorders (Bogenschutz et al., 2015; Johnson et al., 2014, 2017).”
BackgroundPalhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., Mota-Rolim, S. A., Osório, F. L., Sanches, R., dos Santos, R. G., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291718001356 · Cited by 852
Roseman, L., Nutt, D. J., & Carhart-Harris, R. L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00974 · Cited by 808 · cited 2×
“Roseman et al. (2018) found that levels of anxiety and confusion during psilocybin sessions predicted less positive clinical outcomes in depression patients.”
BackgroundSafety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Moreno, F. A., Wiegand, C. B., Taitano, E. K., & Delgado, P. L. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1110 · Cited by 789 · cited 2×
“, 2016), obsessive-compulsive disorder (Moreno et al., 2006), and substance use disorders (Bogenschutz et al.”
BackgroundGasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000113 · Cited by 750 · cited 2×
“, 2019), psychological distress associated with chronic or terminal illness (Agin-Liebes et al., 2020; Anderson et al., 2020; Gasser et al., 2014; Griffiths et al., 2016; Grob et al., 2011; Ross et al., 2016), obsessive-compulsive disorder (Moreno et al.”
BackgroundSerotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739 · cited 2×
“Like most extra-pharmacological conceptions of acute and longerterm psychedelic drug effects (Carhart-Harris and Nutt, 2017), the present theorized model (Figure 1) postulates a mediation effect: Context factors determine the acute drug response, which in turn predicts longer-term outcomes.”
BackgroundLong-term follow-up of psilocybin-facilitated smoking cessation
Johnson, M. W., Garcia-Romeu, A., & Griffiths, R. R. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2016.1170135 · Cited by 696
Psychometric evaluation of the altered states of consciousness rating scale (OAV)
Studerus, E., Gamma, A., & Vollenweider, F. X. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012412 · Cited by 683 · cited 2×
“…used in contemporary research for characterizing acute psychedelic experiences have been developed in one language (mostly English, a notable exception being the originally German Altered States of Consciousness Rating Scale; ASC; Dittrich, 1998; Studerus et al., 2010) and subsequently translated.”
BackgroundPsychedelics and the essential importance of context
Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I., & Kaelen, M. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118754710 · Cited by 657 · cited 4×
“Referring to psychedelicassisted therapies, Carhart-Harris et al. (2018b) concurred that “challenging experiences can indeed be therapeutically beneficial, but only if personal insight and/or an emotional catharsis follows the relevant experience of psychological struggle”.”
BackgroundInfluentialWatts, R., Day, C., Krzanowski, J., Nutt, D., & Carhart-Harris, R. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817709585 · Cited by 589 · cited 3×
“Qualitative studies of patient reports seem to indicate that the succession of initial distress and subsequent relief may be a rather typical course of events in therapeutically effective psychedelic dosing sessions (Belser et al., 2017; Gasser et al., 2015; Watts et al., 2017).”
BackgroundThe Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans
Dittrich, A. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979351 · Cited by 577 · cited 2×
“To our knowledge, all psychometric self-report measures that are regularly used in contemporary research for characterizing acute psychedelic experiences have been developed in one language (mostly English, a notable exception being the originally German Altered States of Consciousness Rating Scale; ASC; Dittrich, 199…”
BackgroundCarbonaro, T. M., Bradstreet, M. P., Barrett, F. S., MacLean, K. A., Jesse, R., Johnson, M. W., & Griffiths, R. R. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116662634 · Cited by 553 · cited 4×
“Under less favorable conditions where “learning to let go” is impeded, persistent avoidance may instead contribute to the escalation and maintenance of distressful states that can be referred to as challenging experiences (Barrett et al., 2016; Carbonaro et al., 2016), and are characterized by panic, desperation, and…”
BackgroundInfluentialHartogsohn, I. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116677852 · Cited by 483 · cited 1×
“•• Context-dependence: Given that acute responses to psychedelics are generally strongly influenced by context (“set and setting”; Carhart-Harris et al., 2018b; Hartogsohn, 2016), ACE and AVE are assumed to depend on context factors such as use motives and a therapeutic setting.”
BackgroundEgo-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI).
Nour, M. M., Evans, L., Nutt, D., & Carhart-Harris, R. L. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00269 · Cited by 470 · cited 2×
“…for retrospective characterization of psychedelic experiences, including measures of “oceanic boundlessness” (Studerus et al., 2010), “ego-dissolution” (Nour et al., 2016), “mystical experience” (MacLean et al., 2012), and “psychological insight” (Davis et al., 2021) use unipolar response formats…”
BackgroundGasser, P., Kirchner, K., & Passie, T. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114555249 · Cited by 456 · cited 4×
“, 2018), and qualitative interviews with patients (Belser et al., 2017; Gasser et al., 2015; Watts et al., 2017) suggests that these drugs’ therapeutic effects are associated with shifts from excessive experiential avoidance (the tendency to avoid or control aversive emotions, sensations, thoughts, or memories despite…”
BackgroundInfluentialPredicting responses to psychedelics: a prospective study
Haijen, E. C. H. M., Kaelen, M., Roseman, L., Timmermann, C., Kettner, H., Russ, S., Nutt, D., Daws, R. E., Hampshire, A. D. G., Lorenz, R., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00897 · Cited by 417 · cited 5×
“This result adds nuance to a previous finding linking recreational psychedelic use with lower rates of challenging experiences (Haijen et al., 2018), and suggests that the distinction between approach-motivated (hedonic) and avoidance-motivated (escapist) recreational use could be important for…”
BackgroundMethodResultInfluentialEmotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
Roseman, L., Haijen, E., Idialu-Ikato, K., Kaelen, M., Watts, R., & Carhart-Harris, R. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119855974 · Cited by 413 · cited 5×
“…AVE and ACE with CEQ and EBI scores, respectively, lend further support to the construct validity of the APEQ, and add some clarity to the role of challenging (Barrett et al., 2016) and emotional breakthrough experiences (Roseman et al., 2019) in determining longer-term responses to psychedelics.”
BackgroundResultInfluentialMacLean, K. A., Leoutsakos, J. S., Johnson, M. W., & Griffiths, R. R. (2012) · Journal for the Scientific Study of Religion · doi:10.1111/j.1468-5906.2012.01685.x · Cited by 405 · cited 2×
“…experiences, including measures of “oceanic boundlessness” (Studerus et al., 2010), “ego-dissolution” (Nour et al., 2016), “mystical experience” (MacLean et al., 2012), and “psychological insight” (Davis et al., 2021) use unipolar response formats (e.g. a visual analogue scale with the…”
BackgroundThe CASMIN Educational Classification in International Comparative Research
Brauns, H., Scherer, S., & Steinmann, S. (2003) · Advances in Cross-National Comparison · doi:10.1007/978-1-4419-9186-7_11 · Cited by 379 · cited 1×
“The latter was assessed using the Comparative Analysis of Social Mobility in Industrial Nations (CASMIN) classification of education (Brauns et al., 2003) to ensure comparability between the English- and the German-language samples.”
MethodDavis, A. K., Barrett, F. S., & Griffiths, R. R. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.004 · Cited by 375 · cited 3×
“Observational and experimental studies in healthy individuals (Smigielski et al., 2019; Soler et al., 2016, 2018) as well as online surveys (Davis et al., 2020a, 2021; Zeifman et al., 2020) suggest that the acceptance-promoting effects of psychedelics are not restricted to their clinical uses.”
BackgroundMethodBarrett, F. S., Bradstreet, M. P., Leoutsakos, J.-M. S., Johnson, M. W., & Griffiths, R. R. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116678781 · Cited by 366 · cited 6×
“…AVE and ACE with CEQ and EBI scores, respectively, lend further support to the construct validity of the APEQ, and add some clarity to the role of challenging (Barrett et al., 2016) and emotional breakthrough experiences (Roseman et al., 2019) in determining longer-term responses to psychedelics.”
BackgroundResultInfluentialA REVIEW OF THE CLINICAL EFFECTS OF PSYCHOTOMIMETIC AGENTS
Osmond, H. (1957) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1957.tb40738.x · Cited by 365 · cited 2×
“According to standard protocols for dosing sessions in current psychedelic therapy research, which are largely consistent with the historical “psychedelic model” (Osmond, 1957; Pahnke et al., 1970), patients are encouraged to direct attention toward the inner experience of emotions, thoughts and bodily sensations whil…”
MethodAgin-Liebes, G. I., Malone, T., Yalch, M. M., Mennenga, S. E., Ponté, K. L., Guss, J., Bossis, A. P., Grigsby, J., Fischer, S., & Ross, S. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119897615 · Cited by 360 · cited 2×
“, 2019), psychological distress associated with chronic or terminal illness (Agin-Liebes et al., 2020; Anderson et al., 2020; Gasser et al., 2014; Griffiths et al., 2016; Grob et al., 2011; Ross et al., 2016), obsessive-compulsive disorder (Moreno et al.”
BackgroundEmotional processing in experiential therapy: Why "the only way out is through."
Pascual-Leone, A., & Greenberg, L. S. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.6.875 · Cited by 322 · cited 2×
“Almost all conceptualizations of psychotherapy share the view that, in order to overcome their emotional problems, patients must come into direct contact with them (Frank, 1961; Grawe, 1997; Orlinsky et al., 1994), that is, “the only way out is through” (Pascual-Leone and Greenberg, 2007).”
BackgroundLSD enhances suggestibility in healthy volunteers
Carhart-Harris, R. L., Kaelen, M., Whalley, M. G., Bolstridge, M., Feilding, A., & Nutt, D. J. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3714-z · Cited by 320 · cited 1×
“One argument in favor of using such complementarity-based rather than one-sided instruments whenever possible is related to the circumstance that psychedelics can increase suggestibility (Carhart-Harris et al., 2015).”
BackgroundADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE
Strassman, R. J. (1984) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198410000-00001 · Cited by 312 · cited 1×
“…plausible given psychedelic drugs’ highly context-dependent effects (Carhart-Harris et al., 2018b), and could explain some of the psychological harms that are indeed sometimes occasioned by psychedelic use in recreational, ceremonial, or underground therapy settings (Cohen, 1966; Strassman, 1984).”
BackgroundBelser, A. B., Agin-Liebes, G., Swift, T. C., Terrana, S., Devenot, N., Friedman, H. L., Guss, J., Bossis, A., & Ross, S. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817706884 · Cited by 311 · cited 4×
“, 2018), and qualitative interviews with patients (Belser et al., 2017; Gasser et al., 2015; Watts et al., 2017) suggests that these drugs’ therapeutic effects are associated with shifts from excessive experiential avoidance (the tendency to avoid or control aversive emotions, sensations, thoughts, or memories despite…”
BackgroundInfluential(2020) · Conducting Health Research: Principles, Process, and Methods · doi:10.4135/9781071909621.n12 · Cited by 310
Psychedelics not linked to mental health problems or suicidal behavior: A population study
Johansen, P.-Ø., & Krebs, T. S. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114568039 · Cited by 302
Anderson, B. T., Danforth, A., Daroff, P. R., Stauffer, C., Ekman, E., Agin-Liebes, G., Trope, A., Boden, M. T., Dilley, P. J., Mitchell, J., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100538 · Cited by 284 · cited 2×
“, 2019), psychological distress associated with chronic or terminal illness (Agin-Liebes et al., 2020; Anderson et al., 2020; Gasser et al., 2014; Griffiths et al., 2016; Grob et al., 2011; Ross et al., 2016), obsessive-compulsive disorder (Moreno et al.”
BackgroundResearch-informed psychotherapy
Grawe, K. (1997) · Psychotherapy Research · doi:10.1080/10503309712331331843 · Cited by 269 · cited 6×
“Through a second type of corrective experience, termed clarification of meaning (Grawe, 1997; Grosse Holtforth et al., 2006), the individual gains awareness and understanding of previously implicit fears and their associations with emotions and behavior.”
BackgroundInfluentialTwo-factor learning theory: Summary and comment
Mowrer, O. H. (1951) · Psychological Review · doi:10.1037/h0058956 · Cited by 233 · cited 1×
“Theories of avoidance commonly assume that avoidance of threatening stimuli is learned by operant conditioning, as avoidant responses typically result in the omission of aversive events that would otherwise occur (i.e. negative reinforcement; Maia, 2010; Mowrer, 1951).”
BackgroundExpectancies as core features of mental disorders
Rief, W., Glombiewski, J. A., Gollwitzer, M., Schubö, A., Schwarting, R., & Thorwart, A. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000184 · Cited by 233 · cited 2×
“On the positive side, this implies opportunities for deep and enduring psychological change from excessive experiential avoidance toward more acceptance—even in otherwise rigid individuals whose avoidancerelated beliefs are in normal waking consciousness resistant to corrective experiences (a common problem in convent…”
BackgroundIncreased amygdala responses to emotional faces after psilocybin for treatment-resistant depression
Roseman, L., Demetriou, L., Wall, M. B., Nutt, D. J., & Carhart-Harris, R. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.041 · Cited by 230 · cited 3×
“, 2016), neuroimaging studies (Mertens et al., 2020; Roseman et al., 2018), and qualitative interviews with patients (Belser et al.”
van Amsterdam, J., Nutt, D., Phillips, L., & van den Brink, W. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581980 · Cited by 229
Hartogsohn, I. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00129 · Cited by 229 · cited 1×
“…process of learning acceptance occurs in the presence of context factors that deploy psychedelics’ potential to elicit highly emotional, personally meaningful experiences (e.g. therapeutic intentions and music; Barrett et al., 2018; Garcia-Romeu and Richards, 2018; Hartogsohn, 2018; Swanson, 2018).”
BackgroundBreeksema, J. J., Niemeijer, A. R., Krediet, E., Vermetten, E., & Schoevers, R. A. (2020) · CNS Drugs · doi:10.1007/s40263-020-00748-y · Cited by 224 · cited 3×
“…where intense emotions are met with exceptional openness are commonly reported, and indeed often described in ways suggestive of underlying psychotherapeutic processes, by psychedelic therapy patients and others who have used psychedelics with therapeutic intent (Breeksema et al., 2020).”
BackgroundAday, J. S., Davis, A. K., Mitzkovitz, C. M., Bloesch, E. K., & Davoli, C. C. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00014 · Cited by 224 · cited 1×
“The spiritual or mystical dimension of the psychedelic experience has received much attention as a potential source of positive change in clinical applications and beyond (Aday et al., 2021).”
BackgroundKettner, H., Rosas, F. E., Timmermann, C., Kärtner, L., Carhart-Harris, R. L., & Roseman, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.623985 · Cited by 221 · cited 3×
“Other questionnaires, such as a recently developed measure of “psychedelic communitas” (Kettner et al., 2021), use a bipolar response format (in this case a Likert-type scale ranging from “strongly disagree” to “strongly agree”).”
BackgroundMethodThe experimental use of psychedelic (LSD) psychotherapy.
Pahnke, W. N. (1970) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1970.03170240060010 · Cited by 220 · cited 1×
“According to standard protocols for dosing sessions in current psychedelic therapy research, which are largely consistent with the historical “psychedelic model” (Osmond, 1957; Pahnke et al., 1970), patients are encouraged to direct attention toward the inner experience of emotions, thoughts and bodily sensations whil…”
MethodLetheby, C. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198843122.001.0001 · Cited by 215 · cited 1×
“Letheby (2021) recently laid out a comprehensive argument that beneficial or therapeutic longer-term changes occasioned by psychedelic drugs are not caused by experience-independent neuropharmacological effects, nor by an (alleged) induction of nonnaturalistic metaphysical ideations, but rather by…”
BackgroundSoler, J., Elices, M., Franquesa, A., Barker, S., Friedlander, P., Feilding, A., Pascual, J. C., & Riba, J. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4162-0 · Cited by 209
Harm potential of magic mushroom use: A review
Amsterdam, J. V., Opperhuizen, A., & Brink, W. V. D. (2011) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2011.01.006 · Cited by 208
Mertens, L. J., Wall, M. B., Roseman, L., Demetriou, L., Nutt, D. J., & Carhart-Harris, R. L. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119895520 · Cited by 208 · cited 2×
“, 2016), neuroimaging studies (Mertens et al., 2020; Roseman et al., 2018), and qualitative interviews with patients (Belser et al.”
BackgroundSelf-citationLearning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance
Wolff, M., Evens, R., Mertens, L. J., Koslowski, M., Betzler, F., Gründer, G., & Jungaberle, H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00005 · Cited by 194 · cited 15×
“…however, this rule can apparently be suspended or even reversed: Rather than bringing relief from threatening private events, avoidant responses to aversive psychedelic experiences often lead to increased distress, presumably especially in uncertain stimulus environments (Wolff et al., 2020).”
BackgroundInfluentialSelf-citationGarcia-Romeu, A., & Richards, W. A. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1486289 · Cited by 189 · cited 7×
“…with the historical “psychedelic model” (Osmond, 1957; Pahnke et al., 1970), patients are encouraged to direct attention toward the inner experience of emotions, thoughts and bodily sensations while lying on a bed or sofa wearing eyeshades and headphones (Garcia-Romeu and Richards, 2018).”
BackgroundInfluentialUnifying Theories of Psychedelic Drug Effects
Swanson, L. R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00172 · Cited by 181 · cited 1×
“…process of learning acceptance occurs in the presence of context factors that deploy psychedelics’ potential to elicit highly emotional, personally meaningful experiences (e.g. therapeutic intentions and music; Barrett et al., 2018; Garcia-Romeu and Richards, 2018; Hartogsohn, 2018; Swanson, 2018).”
BackgroundSmigielski, L., Kometer, M., Scheidegger, M., Krähenmann, R., Huber, T., & Vollenweider, F. X. (2019) · Scientific Reports · doi:10.1038/s41598-019-50612-3 · Cited by 176 · cited 1×
“Observational and experimental studies in healthy individuals (Smigielski et al., 2019; Soler et al., 2016, 2018) as well as online surveys (Davis et al., 2020a, 2021; Zeifman et al., 2020) suggest that the acceptance-promoting effects of psychedelics are not restricted to their clinical uses.”
BackgroundDavis, A. K., Barrett, F. S., So, S., Gukasyan, N., Swift, T. C., & Griffiths, R. R. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120967878 · Cited by 169 · cited 5×
“, 2012), and “psychological insight” (Davis et al., 2021) use unipolar response formats (e.”
BackgroundMethodInfluentialIt’s a Trap! Instructional Manipulation Checks Prompt Systematic Thinking on “Tricky” Tasks
Hauser, D. J., & Schwarz, N. (2015) · Sage Open · doi:10.1177/2158244015584617 · Cited by 168 · cited 1×
“To avoid potentially adverse attentional effects (see Hauser and Schwarz, 2015), no instructional manipulation checks were included in the survey.”
BackgroundPersuasion and Healing: A Comparative Study of Psychotherapy.
Ruesch, J. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710140108018 · Cited by 166
Psychedelic harm reduction and integration: A transtheoretical model for clinical practice
Gorman, I., Nielson, E. M., Molinar, A., Cassidy, K., & Sabbagh, J. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.645246 · Cited by 147 · cited 4×
“One particular form of avoidance-motivated behavior with high potential relevance for psychedelic harm reduction is the phenomenon of spiritual bypass, that is, the tendency to avoid or prematurely transcend emotional issues, developmental tasks, and basic human needs by focusing on spiritual beliefs, practices, and e…”
BackgroundInfluentialTwo-factor theory, the actor--critic model, and conditioned avoidance
Maia, T. V. (2010) · Learning & Behavior · doi:10.3758/lb.38.1.50 · Cited by 144 · cited 1×
“Theories of avoidance commonly assume that avoidance of threatening stimuli is learned by operant conditioning, as avoidant responses typically result in the omission of aversive events that would otherwise occur (i.e. negative reinforcement; Maia, 2010; Mowrer, 1951).”
BackgroundBrouwer, A., & Carhart-Harris, R. L. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120959637 · Cited by 143 · cited 3×
“…mental state,” that is, a temporary window of heightened neural and psychological plasticity where deeply held beliefs are “relaxed” (destabilized and sensitive to new information), and thus become amenable to enduring change (Brouwer and Carhart-Harris, 2020; Carhart-Harris and Friston, 2019).”
BackgroundTimmermann, C., Watts, R., & Dupuis, D. (2022) · Transcultural Psychiatry · doi:10.1177/13634615221082796 · Cited by 119 · cited 1×
“…a result, the individual may acquire strengthened implicit fears and even entirely new “pathogenic meanings” (Frank and Frank, 1993), that is, previously unburdened topics become associated with severe threats to basic psychological needs (see Timmermann et al., 2021, for an illustrative example).”
BackgroundConsciousness, Religion, and Gurus: Pitfalls of Psychedelic Medicine
Johnson, M. W. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00198 · Cited by 114
Zeifman, R. J., Wagner, A. C., Watts, R., Kettner, H., Mertens, L. J., & Carhart-Harris, R. L. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00782 · Cited by 106 · cited 1×
“Observational and experimental studies in healthy individuals (Smigielski et al., 2019; Soler et al., 2016, 2018) as well as online surveys (Davis et al., 2020a, 2021; Zeifman et al., 2020) suggest that the acceptance-promoting effects of psychedelics are not restricted to their clinical uses.”
BackgroundSelf-citationSoler, J., Elices, M., Dominguez-Clavé, E., Pascual, J. C., Feilding, A., Navarro-Gil, M., García-Campayo, J., & Riba, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00224 · Cited by 102 · cited 1×
“Observational and experimental studies in healthy individuals (Smigielski et al., 2019; Soler et al., 2016, 2018) as well as online surveys (Davis et al., 2020a, 2021; Zeifman et al., 2020) suggest that the acceptance-promoting effects of psychedelics are not restricted to their clinical uses.”
BackgroundEffects of External Stimulation on Psychedelic State Neurodynamics
Mediano, P. A. M., Rosas, F. E., Timmermann, C., Roseman, L., Nutt, D. J., Feilding, A., Kaelen, M., Kringelbach, M. L., Barrett, A. B., Seth, A. K., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00289 · Cited by 101
Moving Past Mysticism in Psychedelic Science
Sanders, J. W., & Zijlmans, J. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00097 · Cited by 96 · cited 1×
“…research instruments for measuring them are necessary steps toward overcoming what has been referred to as “psychedelic exceptionalism” and establishing a demystified scientific understanding of the psychedelic state and its transformative potential (Johnson, 2021; Sanders and Zijlmans, 2021).”
BackgroundPsychedelics and music: neuroscience and therapeutic implications
Barrett, F. S., Preller, K. H., & Kaelen, M. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1484342 · Cited by 86 · cited 2×
“…process of learning acceptance occurs in the presence of context factors that deploy psychedelics’ potential to elicit highly emotional, personally meaningful experiences (e.g. therapeutic intentions and music; Barrett et al., 2018; Garcia-Romeu and Richards, 2018; Hartogsohn, 2018; Swanson, 2018).”
BackgroundReplication and extension of a model predicting response to psilocybin
Russ, S. L., Carhart-Harris, R. L., Maruyama, G. M., & Elliott, M. S. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05279-z · Cited by 85
Harms associated with psychoactive substances: findings of the UK National Drug Survey
Morgan, C. J., Muetzelfeldt, L., Muetzelfeldt, M., Nutt, D. J., & Curran, H. V. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109106915 · Cited by 80 · cited 1×
“Like our present results, this may be read as evidence for the relatively low risk–benefit ratio associated with psychedelic use (Johansen and Krebs, 2015; Morgan et al., 2010; Van Amsterdam et al., 2011, 2015).”
ResultA Classification of LSD Complications
Cohen, S. (1966) · Psychosomatics · doi:10.1016/s0033-3182(66)72149-5 · Cited by 74 · cited 2×
“, 2018b), and could explain some of the psychological harms that are indeed sometimes occasioned by psychedelic use in recreational, ceremonial, or underground therapy settings (Cohen, 1966; Strassman, 1984).”
BackgroundPsychedelics and psychotherapy
Nayak, S., & Johnson, M. W. (2021) · Pharmacopsychiatry · doi:10.1055/a-1312-7297 · Cited by 71 · cited 2×
“…it builds on empirically well-established general psychotherapeutic change mechanisms that are straightforwardly related to therapeutic methods and competencies (Grawe, 1997; for a recent argument in favor of applying the “common factors” view to psychedelic therapy, see Nayak and Johnson, 2020).”
BackgroundGandy, S., Forstmann, M., Carhart-Harris, R. L., Timmermann, C., Luke, D., & Watts, R. (2020) · Health Psychology Open · doi:10.1177/2055102920978123 · Cited by 63 · cited 1×
“It is noteworthy, however, that there are other potential mediators of therapeutic effects for which a more interactive setting is likely conducive, such as experiences of social connectedness (Kettner et al., 2021) or nature-relatedness (Gandy et al., 2020).”
BackgroundStates and traits related to the quality and consequences of psychedelic experiences.
Russ, S. L., Carhart-Harris, R. L., Maruyama, G., & Elliott, M. S. (2019) · Psychology of Consciousness: Theory, Research, and Practice · doi:10.1037/cns0000169 · Cited by 55 · cited 1×
“Relatedly, previous studies have provided evidence that verbal interactions during psilocybin sessions may hinder the emergence of mystical-type experiences (Russ et al., 2019a,b).”
BackgroundPsychologische Flexibilität messen: Der Fragebogen zu Akzeptanz und Handeln II
Hoyer, J., & Gloster, A. T. (2013) · Verhaltenstherapie · doi:10.1159/000347040 · Cited by 53 · cited 1×
“The Acceptance and Action Questionnaire II (AAQ-II; Bond et al., 2011; German version by Hoyer and Gloster, 2013), measures psychological (in-)flexibility using seven items (e.g. “I am afraid of my feelings”) which are rated on a Likert-type scale from 1 (“never true”) to 7 (“always true”).”
MethodThe Potential Role of Psychedelic Drugs in Mental Health Care of the Future
Gründer, G., & Jungaberle, H. (2021) · Pharmacopsychiatry · doi:10.1055/a-1486-7386 · Cited by 45 · cited 1×
“Such an understanding is not a mere academic issue but has important implications regarding the question how psychedelic-assisted therapies should be delivered and how therapists should be trained (Gründer and Jungaberle, 2021).”
BackgroundThe corrective experience: A core principle for therapeutic change.
Goldfried, M. R. (2012) · American Psychological Association eBooks · doi:10.1037/13747-002 · Cited by 32 · cited 1×
“…circumstances, the conditioned ability to confront the arising emotional material in a largely non-avoidant manner may lead to acceptancepromoting insights similar to those obtained through the kinds of “corrective experiences” (Goldfried, 2012) that are purposefully induced in psychotherapy.”
ResultHoltforth, M. G., Grawe, K., & Castonguay, L. G. (2006) · Psychotherapy Research · doi:10.1080/10503300600608215 · Cited by 29 · cited 1×
“Through a second type of corrective experience, termed clarification of meaning (Grawe, 1997; Grosse Holtforth et al., 2006), the individual gains awareness and understanding of previously implicit fears and their associations with emotions and behavior.”
BackgroundTimmermann, C. B., Watts, R., & Dupuis, D. (2020) · doi:10.31234/osf.io/j5768 · Cited by 27
Dworatzyk, K., Jansen, T., & Schmidt, T. T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264927 · Cited by 22 · cited 1×
“The Challenging Experience Questionnaire (CEQ; Barrett et al., 2016; German version by Dworatzyk et al., 2021) was developed as a multidimensional measure of different aspects of psychologically difficult experiences during the acute effects of psychedelics.”
Kangaslampi, S. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05703-9 · Cited by 21 · cited 1×
“…not technically allow for the identification of mediation effects (for an in-depth discussion of mediation analysis in psychedelic research, see Kangaslampi, 2020), the SEM summarized in Figure 3 is consistent with the mediation assumption and may provide preliminary evidence that ACE and AVE…”
ResultQuestion Wording and Item Formulation
Elson, M. (2017) · Wiley eBooks · doi:10.1002/9781118901731.iecrm0200 · Cited by 13 · cited 1×
“Based on the pre-defined theoretical constructs explained above, and following general recommendations for item formulation (Elson, 2017), the authors of the present article crafted a pool of 57 candidate items.”
MethodDworatzyk, K., Jansen, T., & Schmidt, T. T. (2021) · doi:10.31234/osf.io/kxmgq · Cited by 3
Research works printed but not linked: 1
- Jungaberle H Gasser P Weinhold J, et al. (2008) Therapie mit psychoaktiven Substanzen. Bern: Hogrefe AG.
Cited by
Treatment with psychedelics is psychotherapy: beyond reductionism
Gründer, G., Brand, M., Mertens, L. J., Jungaberle, H., Kärtner, L., Scharf, D., Spangemacher, M., & Wolff, M. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00363-2 · Cited by 129
Self-citationTulver, K., Kaup, K., Laukkonen, R., & Aru, J. (2023) · Consciousness and Cognition · doi:10.1016/j.concog.2023.103494 · Cited by 100
Clinically relevant acute subjective effects of psychedelics beyond mystical experience
Yaden, D. B., Goldy, S. P., Weiss, B., & Griffiths, R. R. (2024) · Nature Reviews Psychology · doi:10.1038/s44159-024-00345-6 · Cited by 72
“…has been observed for the Challenging Experience Questionnaire relative to a set of positively valenced measures (Mystical Experience Questionnaire, Ego Dissolution Inventory, Emotional Breakthrough Inventory, Avoidance-Promoting Experiences and Psychological Insight Questionnaire) 21,76,78 .”
InfluentialZeifman, R. J., Wagner, A. C., Monson, C. M., & Carhart-Harris, R. L. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.04.105 · Cited by 60
Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms
Calder, A. E., Mock, S., Friedli, N., Pasi, P., & Hasler, G. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.05.008 · Cited by 55
Metadata
- Authors
- Wolff, M., Mertens, L. J., Walter, M., Enge, S., & Evens, R.
- Affiliations
- Humboldt-Universität zu Berlin (DE)
- Heidelberg University (DE)
- Johannes Gutenberg University Mainz (DE)
- MSB Medical School Berlin (DE)
- Corresponding author
- Wolff, Max
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2022-03
- Volume
- 36
- Issue
- 3
- Pages
- 387-408
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- PMC
- PMC8902683
- OpenAlex
- W4221108429
- Cited by
- 58
- References
- 98
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 16 · 2023: 12 · 2022: 3
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Psychopharmacology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Keywords
- psychedelics, acceptance, avoidance, psychological flexibility, LSD, psilocybin, mescaline, ayahuasca, use motives, therapeutic applications, questionnaire validation
- MeSH terms
- Hallucinogens, Humans, Lysergic Acid Diethylamide, Prospective Studies, Psilocybin, Surveys and Questionnaires, Retrospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.